- Home
- products
- north america
- liquid biopsy
Show results for
Refine by
Liquid Biopsy Equipment Supplied In North America
33 equipment items found
Manufactured by:Rarecells Diagnostics SAS based inParis Cedex 06, FRANCE
Cancer is the second cause of death, accounting for nearly 9 million deaths in 2017 all over the world. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. It is estimated that metastasis is the primary cause of 90% of all cancer-related deaths. Circulating Tumor Cells (CTCs) detection and analysis are the foundation of non-invasive tests ...
Manufactured by:Kailos Genetics, LLC. based inHuntsville, ALABAMA (USA)
The Iota assay detects methylation differences in a person’s blood sample, the superior choice for early disease detection. The process of detecting these changes is called a methylated liquid biopsy and it can be used as a companion to standard imaging protocols such as mammograms and low dose CT scans among others. Because methylated ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark’s initial liquid biopsy assay detects SSAT1 using an FDA approved drug. SSAT1 is an enzyme with elevated levels in numerous cancers. The assay targets a well researched and understood metabolic pathway. BioMark of a few unique companies using safe therapeutic agents for diagnostic indication. ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark has invested in and developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early stage diagnosis of lung ...
Manufactured by:OTraces Inc. based inSykesville, MARYLAND (USA)
TME Liquid Biopsy Dx immunoassay test for assessing progression of low Gleason Score prostate cancer to high Gleason Score aggressive prostate cancer, Active ...
Manufactured by:Oasis Diagnostics based inVancouver, WASHINGTON (USA)
RNAPro•SAL was developed as an easy to use and cost effective tool for the split sample collection of rich sources of RNA miRNA, mRNA and proteins found in saliva. The proprietary RNAPro•SAL kit provides two equivalent samples of saliva which total 1.0 mL of saliva in 1-3 minutes. These may be analyzed later for either RNA or protein components. A unique built in Sample Volume Adequacy ...
Manufactured by:Nucleix Ltd. based inSan Diego, CALIFORNIA (USA)
Liquid biopsies are a new powerful tool in cancer diagnostics that is transforming patient healthcare. Body fluids such as blood or urine are obtained from the patient and analyzed for the presence of circulating tumor DNA which is shed from the cancer. This DNA can tell if cancer is present, its type, effective medications, and more. Liquid ...
by:BillionToOne Inc. based inMenlo Park, CALIFORNIA (USA)
Shifting the Paradigm of Prenatal Screening: The name of our non-invasive prenatal test (NIPT) is appropriately called “UNITY” as it brings together fetal screening for aneuploidies and recessive conditions. It also represents uniting pregnant patients in more equitable ...
Manufactured by:DELEE Corp based in, CALIFORNIA (USA)
CytoCatch™ is a patent pending technology that consists of an isolation platform and an imaging system created to effectively isolate and analyze CTCs from blood samples. ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
Manufactured by:Twist Bioscience based inSouth San Francisco, CALIFORNIA (USA)
NGS-based liquid biopsy is a rapidly evolving application that requires accurate and precise reference standards. The Twist Pan-cancer Reference Standard is a high-quality, standardized control for use in the research and development of NGS-based liquid biopsy assays. ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ’s NETs technology is a sample preparation platform with the potential to revolutionise the performance of liquid biopsy diagnostic assays. The market potential for liquid biopsy applications is estimated at billions of dollars ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
RaDaR™ is a personalized, multi-tumor liquid biopsy assay that can track a set of up to 48 tumor-specific variants in a patient using a liquid biopsy with exceptional sensitivity. This allows RaDaR™ to detect traces of molecular residual disease (MRD) in a patient following surgery or other treatment for cancer, ...
by:NeoGenomics Laboratories based inFort Myers, FLORIDA (USA)
InVisionFirst®-Lung, a ctDNA NGS liquid biopsy testing 37 genes relevant to the care of patients with advanced NSCLC. Covered for Medicare and other private insurance NSCLC patients who meet specific clinical criteria in the United States. InVisionFirst-Lung® is available world-wide for both commercial and research use. ...
by:BillionToOne Inc. based inMenlo Park, CALIFORNIA (USA)
Our molecular counting platform can help quantify nearly undetectable DNA changes, unlocking improvements to non-invasive prenatal screening and liquid ...
Manufactured by:Oasis Diagnostics based inVancouver, WASHINGTON (USA)
The Pure•SAL Oral Specimen Collection Kit provides a simple non-invasive and rapid platform for isolating “liquid biopsy” specimens including cell free DNA, cell free RNA, exosomes, or proteins in a single step. The harvested, purified saliva specimen is stabilized if required and available for downstream PCR, genotyping, sequencing, proteomics ...
Manufactured by:Biocept based inSan Diego, CALIFORNIA (USA)
Biocept’s Target Selector™ molecular assay kits detect key oncogene mutations through the analysis of both Formalin-Fixed Paraffin-Embedded (FFPE) tissue gained from surgical biopsies as well as circulating tumor DNA (ctDNA) gained from blood-based liquid biopsies. The EGFR pathway can include mutations that are among the most ...
Manufactured by:Streck, Inc. based inLa Vista, NEBRASKA (USA)
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The initial test delivered by the miR Disease Management Platform® is the miR Sentinel™ Prostate Cancer Test, the first and only standalone, non-invasive liquid biopsy urine test that accurately detects, classifies and can monitor prostate cancer at the molecular level. ...